MedTrace Logo

AI Screening for BDD in Aesthetic Surgery: Enhancing Safety and Outcomes

NCT06584305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3722

Last updated 2024-09-04

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the effectiveness of an AI-powered screening tool for Body Dysmorphic Disorder (BDD) among patients seeking aesthetic surgery. The study aims to determine if the AI system can effectively identify patients at risk for BDD and assess the impact of early psychological intervention on surgical decision-making and outcomes. Participants will complete a comprehensive AI-based risk assessment, which includes the Body Dysmorphic Disorder Questionnaire (BDDQ). The study will track the correlation between BDD, age, stress levels, and gender to better understand the prevalence and implications of BDD in cosmetic surgery.

Conditions

  • Body Dysmorphic Disorder

Interventions

PROCEDURE

AI-Powered Body Dysmorphic Disorder Screening Procedure

The AI-Powered Body Dysmorphic Disorder Screening Procedure involves using an AI tool to evaluate patients for Body Dysmorphic Disorder (BDD) before undergoing elective cosmetic surgery. The screening integrates the Body Dysmorphic Disorder Questionnaire (BDDQ) with additional psychological assessments. The AI system processes the collected data to produce a risk score, guiding surgeons in making informed decisions about the need for psychological evaluation or intervention, and determining the suitability of patients for surgery.

Sponsors & Collaborators

  • Bukret Plastic Surgery

    lead OTHER

Principal Investigators

  • Williams E Bukret, MD, EMBA · Bukret Plastic Surgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-02
Primary Completion
2024-08-23
Completion
2024-08-23

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06584305 on ClinicalTrials.gov